{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:57:30Z","timestamp":1793883450714,"version":"4.7.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Hospital-acquired infections (HI) and associated antimicrobial use (AU) significantly contribute to antimicrobial resistance. We aimed to analyse AU patterns for HI treatment in German acute care hospitals.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We analysed data from the German 2022 point prevalence survey (PPS) on AU and healthcare-associated infections, using the European Centre for Disease Prevention and Control protocol across 252 hospitals. Analyses focused on key infection prevention and control (IPC), antimicrobial stewardship (AMS) indicators and AU for HI, categorised by the World Health Organisation AWaRe classification. Comparisons were made to the previous national PPS in 2016 and 2011.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 22 422 antimicrobial prescriptions were recorded in 66 586 patients. HI treatment accounted for 20% of AU. Penicillins with beta-lactamase inhibitors, carbapenems and third-generation cephalosporins accounted for over 50% of AU for HI treatment. <jats:italic>Watch<\/jats:italic> antimicrobials dominated HI treatment prescriptions, accounting for around 62% of use, particularly in respiratory infections, while use of <jats:italic>Access<\/jats:italic> antimicrobials was limited (24%). Skin and soft tissue as well as bone and joint infections, respiratory infections, and urinary tract infections were the most commonly treated HI. Over time, IPC indicators, such as alcohol-based hand rub consumption and IPC staffing, improved significantly, yet AMS staffing remained low and comprehensive hospital-wide post-prescription reviews were limited to around a quarter of hospitals.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The findings underscore the importance of reducing HI to curb the use of broad-spectrum antimicrobials in German hospitals. IPC should be included in AMS strategies, alongside aspects like improving AMS staffing and establishing post-prescription review programmes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13756-025-01608-4","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T18:03:54Z","timestamp":1752775434000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Broad-spectrum and Watch antimicrobials are commonly used to treat hospital-acquired infections in German acute care hospitals: results from the 2022 national point prevalence survey"],"prefix":"10.1186","volume":"14","author":[{"given":"Seven Johannes Sam","family":"Aghdassi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selin","family":"Saydan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frieder","family":"Pf\u00e4fflin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam Songa","family":"Stegemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Theloe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Behnke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Alberto","family":"Pe\u00f1a Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Gropmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Geffers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brar","family":"Piening","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"key":"1608_CR1","doi-asserted-by":"crossref","unstructured":"Plachouras D, Karki T, Hansen S, Hopkins S, Lyytikainen O, Moro ML, et al. Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017. Euro Surveill. 2018;23(46):1800393.","DOI":"10.2807\/1560-7917.ES.23.46.1800393"},{"issue":"1","key":"1608_CR2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","volume":"19","author":"A Cassini","year":"2019","unstructured":"Cassini A, Hogberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56\u201366.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"1608_CR3","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1086\/651094","volume":"31","author":"GA Filice","year":"2010","unstructured":"Filice GA, Nyman JA, Lexau C, Lees CH, Bockstedt LA, Como-Sabetti K, et al. Excess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection. Infect Control Hosp Epidemiol. 2010;31(4):365\u201373.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1608_CR4","unstructured":"GLASS guide for national surveillance systems for monitoring antimicrobial consumption in hospitals. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO."},{"issue":"10325","key":"1608_CR5","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"RC Antimicrobial","year":"2022","unstructured":"Antimicrobial RC. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629\u201355.","journal-title":"Lancet"},{"key":"1608_CR6","unstructured":"European Centre for Disease Prevention and Control. Point prevalence survey of healthcareassociated infections and antimicrobial use in European acute care hospitals \u2013 protocol version 6.1. Stockholm: ECDC; 2022."},{"issue":"38","key":"1608_CR7","first-page":"627","volume":"110","author":"M Behnke","year":"2013","unstructured":"Behnke M, Hansen S, Leistner R, Diaz LA, Gropmann A, Sohr D, et al. Nosocomial infection and antibiotic use: a second national prevalence study in Germany. Dtsch Arztebl Int. 2013;110(38):627\u201333.","journal-title":"Dtsch Arztebl Int"},{"issue":"50","key":"1608_CR8","first-page":"851","volume":"114","author":"M Behnke","year":"2017","unstructured":"Behnke M, Aghdassi SJ, Hansen S, Diaz LAP, Gastmeier P, Piening B. The Prevalence of Nosocomial Infection and Antibiotic Use in German Hospitals. Dtsch Arztebl Int. 2017;114(50):851\u20137.","journal-title":"Dtsch Arztebl Int"},{"issue":"9","key":"1608_CR9","first-page":"277","volume":"121","author":"SJS Aghdassi","year":"2024","unstructured":"Aghdassi SJS, Hansen S, Pena Diaz LA, Gropmann A, Saydan S, Geffers C, et al. Healthcare-Associated Infections and the Use of Antibiotics in German Hospitals. Dtsch Arztebl Int. 2024;121(9):277\u201383.","journal-title":"Dtsch Arztebl Int"},{"issue":"4","key":"1608_CR10","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1093\/jac\/dkx494","volume":"73","author":"SJS Aghdassi","year":"2018","unstructured":"Aghdassi SJS, Gastmeier P, Piening BC, Behnke M, Pena Diaz LA, Gropmann A, et al. Antimicrobial usage in German acute care hospitals: results of the third national point prevalence survey and comparison with previous national point prevalence surveys. J Antimicrob Chemother. 2018;73(4):1077\u201383.","journal-title":"J Antimicrob Chemother"},{"key":"1608_CR11","unstructured":"Web Annex C. WHO AWaRe (access, watch, reserve) classification of antibiotics for evaluation and monitoring of use, 2023. In: The selection and use of essential medicines 2023: Executive summary of the report of the 24th WHO Expert Committee on the Selection and Use of Essential Medicines, 24 \u2013 28 April 2023. Geneva: World Health Organization; 2023 (WHO\/MHP\/HPS\/EML\/2023.04). Licence: CC\u00a0BY-NC-SA\u00a03.0\u00a0IGO."},{"key":"1608_CR12","unstructured":"R Core Team (2023). A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL www.R-project.org\/."},{"key":"1608_CR13","unstructured":"Stevenson M, Sergeant E, Nunes T, et al.: epiR: Tools for the Analysis of Epidemiological Data. R package version 2.0.58, 2023. www.CRAN.R-project.org\/package=epiR."},{"key":"1608_CR14","unstructured":"European Centre for Disease Prevention and Control. Point prevalence survey of healthcareassociated infections and antimicrobial use in European acute care hospitals. Stockholm: ECDC; 2024."},{"issue":"1","key":"1608_CR15","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1186\/s12879-024-09487-7","volume":"24","author":"A Antonelli","year":"2024","unstructured":"Antonelli A, Ales ME, Chiecca G, Dalla Valle Z, De Ponti E, Cereda D, et al. Healthcare-associated infections and antimicrobial use in acute care hospitals: a point prevalence survey in Lombardy, Italy, in 2022. BMC Infect Dis. 2024;24(1):632.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"1608_CR16","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1093\/cid\/ciae253","volume":"79","author":"BF Teshome","year":"2024","unstructured":"Teshome BF, Park T, Arackal J, Hampton N, Kollef MH, Micek ST. Preventing New Gram-negative Resistance Through Beta-lactam De-escalation in Hospitalized Patients With Sepsis: A Retrospective Cohort Study. Clin Infect Dis. 2024;79(4):826\u201333.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"1608_CR17","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1007\/s12325-020-01390-2","volume":"37","author":"I Lakbar","year":"2020","unstructured":"Lakbar I, De Waele JJ, Tabah A, Einav S, Martin-Loeches I, Leone M. Antimicrobial De-Escalation in the ICU: From Recommendations to Level of Evidence. Adv Ther. 2020;37(7):3083\u201396.","journal-title":"Adv Ther"},{"key":"1608_CR18","unstructured":"European Centre for Disease Prevention and Control. Antimicrobial consumption in the EU\/EEA (ESAC-Net) - Annual Epidemiological Report 2022. Stockholm: ECDC; 2023."},{"issue":"1","key":"1608_CR19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-0043-121734","volume":"72","author":"K Dalhoff","year":"2018","unstructured":"Dalhoff K, Abele-Horn M, Andreas S, Deja M, Ewig S, Gastmeier P, et al. Epidemiology, Diagnosis and Treatment of Adult Patients with Nosocomial Pneumonia - Update 2017\u2013S3 Guideline of the German Society for Anaesthesiology and Intensive Care Medicine, the German Society for Infectious Diseases, the German Society for Hygiene and Microbiology, the German Respiratory Society and the Paul-Ehrlich-Society for Chemotherapy, the German Radiological Society and the Society for Virology. Pneumologie. 2018;72(1):15\u201363.","journal-title":"Pneumologie"},{"key":"1608_CR20","doi-asserted-by":"crossref","unstructured":"Torres A, Niederman MS, Chastre J, Ewig S, Fernandez-Vandellos P, Hanberger H, et al. International ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)\/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociacion Latinoamericana del Torax (ALAT). Eur Respir J. 2017;50(3):1700582.","DOI":"10.1183\/13993003.00582-2017"},{"issue":"2 Suppl","key":"1608_CR21","doi-asserted-by":"publisher","first-page":"373S","DOI":"10.1378\/chest.119.2_suppl.373S","volume":"119","author":"JP Lynch 3rd","year":"2001","unstructured":"Lynch JP 3rd. Hospital-acquired pneumonia: risk factors, microbiology, and treatment. Chest. 2001;119(2 Suppl):373S-S384.","journal-title":"Chest"},{"key":"1608_CR22","doi-asserted-by":"crossref","unstructured":"Benko R, Matuz M, Peto Z, Weist K, Heuer O, Vlahovic-Palcevski V, et al. Trends in the hospital-sector consumption of the WHO AWaRe Reserve group antibiotics in EU\/EEA countries and the United Kingdom, 2010 to 2018. Euro Surveill. 2022;27(41):2101058.","DOI":"10.2807\/1560-7917.ES.2022.27.41.2101058"},{"key":"1608_CR23","unstructured":"European Centre for Disease Prevention and Control. Antimicrobial consumption in the EU\/EEA (ESAC-Net) - Annual Epidemiological Report 2023. Stockholm: ECDC; 2024."},{"key":"1608_CR24","doi-asserted-by":"crossref","unstructured":"Shallal A, Lahoud C, Merhej D, Youssef S, Verkler J, Kaljee L, et al. The Impact of a Post-Prescription Review and Feedback Antimicrobial Stewardship Program in Lebanon. Antibiotics (Basel). 2022;11(5):642.","DOI":"10.3390\/antibiotics11050642"},{"issue":"12","key":"1608_CR25","first-page":"e49935","volume":"15","author":"SN Khadse","year":"2023","unstructured":"Khadse SN, Ugemuge S, Singh C. Impact of Antimicrobial Stewardship on Reducing Antimicrobial Resistance. Cureus. 2023;15(12):e49935.","journal-title":"Cureus"},{"issue":"5","key":"1608_CR26","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/cid\/ciw780","volume":"64","author":"PD Tamma","year":"2017","unstructured":"Tamma PD, Avdic E, Keenan JF, Zhao Y, Anand G, Cooper J, et al. What Is the More Effective Antibiotic Stewardship Intervention: Preprescription Authorization or Postprescription Review With Feedback? Clin Infect Dis. 2017;64(5):537\u201343.","journal-title":"Clin Infect Dis"},{"key":"1608_CR27","doi-asserted-by":"crossref","unstructured":"Bundesverband Deutscher Krankenhausapotheker e. V, Deutsche Gesellschaft fur Hygiene und Mikrobiologie e. V, Deutsche Gesellschaft fur Infektiologie e. V, Deutsche Gesellschaft fur Krankenhaushygiene e. V, Deutsche Gesellschaft fur Padiatrische Infektiologie e. V, Kommission Antiinfektiva RuTbRK-I, et al. [Organisational and staff requirements for antimicrobial stewardship activities in hospitals : Position paper of the Commission on Anti-Infectives, Resistance and Therapy (Commission ART) at the Robert Koch Institute, with advice from professional associations]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020;63(6):749\u201360.","DOI":"10.1007\/s00103-020-03152-5"},{"issue":"1","key":"1608_CR28","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1017\/ash.2023.423","volume":"3","author":"OM Scholz","year":"2023","unstructured":"Scholz OM, Kruger N, Betzold E, Bader J, Thul N, Papan C. Antimicrobial stewardship in medical education in Germany: a brief survey and a students\u2019 and educator\u2019s call for change. Antimicrob Steward Healthc Epidemiol. 2023;3(1):e159.","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"issue":"7","key":"1608_CR29","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1093\/jac\/dkac112","volume":"77","author":"BA Van Dort","year":"2022","unstructured":"Van Dort BA, Penm J, Ritchie A, Baysari MT. The impact of digital interventions on antimicrobial stewardship in hospitals: a qualitative synthesis of systematic reviews. J Antimicrob Chemother. 2022;77(7):1828\u201337.","journal-title":"J Antimicrob Chemother"},{"key":"1608_CR30","doi-asserted-by":"publisher","first-page":"101183","DOI":"10.1016\/j.imu.2023.101183","volume":"37","author":"NE Trotter","year":"2023","unstructured":"Trotter NE, Slight SP, Karimi R, Bates DW, Sheikh A, Weir C, et al. The effect of digital antimicrobial stewardship programmes on antimicrobial usage, length of stay, mortality and cost. Informatics in Medicine Unlocked. 2023;37:101183.","journal-title":"Informatics in Medicine Unlocked"},{"key":"1608_CR31","unstructured":"Statistische \u00c4mter des Bundes und der L\u00e4nder: Verzeichnis der Krankenh\u00e4user und Vorsorge- oder Rehabilitationseinrichtungen in Deutschland 2019. [Statistical Offices of the Federal and State Governments: Directory of Hospitals and Preventive or Rehabilitation Facilities in Germany 2019.] https:\/\/www.statistischebibliothek.de\/mir\/receive\/DEHeft_mods_00149046."}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-025-01608-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-025-01608-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-025-01608-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T13:18:54Z","timestamp":1757251134000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-025-01608-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1608"],"URL":"https:\/\/doi.org\/10.1186\/s13756-025-01608-4","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,17]]},"assertion":[{"value":"1 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Data collection and analysis were performed in accordance with the legal surveillance requirements specified in the German Infection Protection Act. Therefore, neither ethics committee approval nor informed consent was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable, because all data were collected within the context of the surveillance of healthcare-associated infections conducted in accordance with the German Protection against Infection Act.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Seven Johannes Sam Aghdassi serves as an Associate Editor for Antimicrobial Resistance & Infection Control. The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"90"}}